Patents by Inventor Jeevanandam ARUMUGASAMY

Jeevanandam ARUMUGASAMY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11299469
    Abstract: Provided herein are methods of preparation of I by reacting i with acid where R1 and R2 are each independently a leaving group. Intermediates to make i are also claimed.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: April 12, 2022
    Assignee: Sumitomo Dainippon Pharma Oncology, Inc.
    Inventors: Jeevanandam Arumugasamy, Wei Li
  • Publication number: 20210107883
    Abstract: Provided herein are methods of preparation of I by reacting i with acid where R1 and R2 are each independently a leaving group. Intermediates to make i are also claimed.
    Type: Application
    Filed: November 29, 2017
    Publication date: April 15, 2021
    Applicant: Sumitomo Dainippon Pharma Oncology, Inc.
    Inventors: Jeevanandam Arumugasamy, Wei LI
  • Publication number: 20140112886
    Abstract: Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds comprise two 2?-methyl nucleotides linked according to Formula I: N1-L-N2??(I) or a pharmaceutically acceptable salt, ester, solvate, stereoisomer, isomeric form, tautomeric form or polymorphic form thereof; wherein N1, L and N2 are as described herein.
    Type: Application
    Filed: October 18, 2013
    Publication date: April 24, 2014
    Inventors: Adel M. MOUSSA, Benjamin Alexander MAYES, Jeevanandam ARUMUGASAMY, Jingyang WANG